Eusol Biotech Co (ROCO:6652) Growth Rank : 0 (As of Dec. 13, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co Growth Rank?

Eusol Biotech Co has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Eusol Biotech Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Eusol Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Minsheng E. Road, 6th Floor, No.135, Sec.3, Songshan District, Taipei, TWN, 10546

Website

http://www.eusol.com.tw

Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines